50P Can We Learn from Failures? A Systematic Review and Metanalysis of Phase III Trials in Platinum Resistant Ovarian Cancer

Despite considerable efforts, little advances have been made in the treatment of platinum resistant ovarian cancer (PROC) in the last decade. The reasons for these dismal results remain controversial. Understanding phase (Ph) 3 randomized controlled trials (RCT) design and outcomes in PROC patients might provide indications for the development of future research.